Monday’s Midday Stock Update: Second Sight Medical Products (EYES), Goodrich Petroleum (GDP), Tesla (TSLA), Rite Aid (RAD), uniQure (QURE)

So far Monday, February 3, NASDAQ is up 2.83% and the S&P is up 1.37%. Here are this morning’s most active stocks: Second Sight Medical Products (EYESResearch Report), Goodrich Petroleum (GDPResearch Report), Tesla (TSLAResearch Report), Rite Aid (RADResearch Report) and uniQure (QUREResearch Report).

Second Sight Medical Products is down -13.93% in midday trading to $5.25. Shares opened today at $6.10. The company has a 52-week low of $3.56 and a 52-week high of $9.60. On the Street’s front, the average 12-month analyst price target for the stock is $20.00, marking a 227.87% potential upside from current levels. In a report issued on November 15, H.C. Wainwright analyst Amit Dayal maintained a Buy rating on EYES, with a price target of $20.00, which implies an upside of 228% from current levels.

Goodrich Petroleum is up 9.46% in midday trading to $7.24. Shares opened today at $6.61. The company has a 52-week low of $6.53 and a 52-week high of $15.24. On the Street’s front, the average 12-month analyst price target for the stock is $14.33, marking a 116.79% potential upside from current levels. In a report issued on January 21, Suntrust Robinson Humphrey analyst Welles Fitzpatrick maintained a Buy rating on GDP, with a price target of $12.00, which implies an upside of 82% from current levels.

Tesla is up 8.66% in midday trading to $732.00. Shares opened today at $673.69. The company has a 52-week low of $176.99 and a 52-week high of $738.00. On the Street’s front, the average 12-month analyst price target for the stock is $496.15, marking a -26.35% potential downside from current levels. In a report released today, Argus analyst Bill Selesky maintained a Buy rating on TSLA, with a price target of $808.00, which implies an upside of 20% from current levels. Separately, on January 30, Bernstein Research’s Toni Sacconaghi reiterated a Hold rating on the stock and has a price target of $325.00. Over the last 3 months, the insider sentiment on Tesla has been negative based on 53 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Rite Aid is up 6.23% in midday trading to $12.54. Shares opened today at $11.80. The company has a 52-week low of $5.04 and a 52-week high of $23.88. On the Street’s front, the average 12-month analyst price target for the stock is $12.00, marking a 1.69% potential upside from current levels. In a report issued on December 23, Deutsche Bank analyst George Hill maintained a Sell rating on RAD, with a price target of $12.00, which represents a slight upside potential from current levels.

uniQure is up 5.83% in midday trading to $60.30. Shares opened today at $56.98. The company has a 52-week low of $33.02 and a 52-week high of $82.49. On the Street’s front, the average 12-month analyst price target for the stock is $91.00, marking a 59.71% potential upside from current levels. In a report issued on January 30, H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Buy rating on QURE, with a price target of $73.00, which represents a potential upside of 28% from where the stock is currently trading. In the last 30 days, insiders have sold $1.57M worth of QURE shares. Over the last 3 months, the insider sentiment on uniQure has been negative based on 47 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.